Bright Minds Biosciences Inc (DRUG) Stock Price, Quote & News

Company Profile

Bright Minds Biosciences Inc., a biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States. Its portfolio of selective 5-HT receptor agonists includes 5-HT2C, 5-HT2A, and 5-HT2C/A for the treatment of epilepsy, pain, and neuropsychiatry; and BMB-101 which completes phase 1 trial for undisclosed seizure disorder. The company also develops BMB-201 and BMB-202 for the treatment of neuropsychiatry and neurology indicatio...

Industry: Biotechnology

Sector: Healthcare

Phone: 647 865 8622

Website: brightmindsbio.com

Address:

19 Vestry Street, New York, United States

EverythingIBuyPumpsHuge Aug. 18 at 7:20 PM

$WINT is a new $DRUG come join the squeeze $KIDZ $INTC $AMZN

0 · Reply

EverythingIBuyPumpsHuge Aug. 18 at 7:20 PM

$WINT is a new $DRUG come join the squeeze $ASST $ASBP $ETH.X

0 · Reply

EverythingIBuyPumpsHuge Aug. 18 at 7:18 PM

$WINT is a new $DRUG come join the squeeze $COIN $BTC.X $HKD

0 · Reply

EverythingIBuyPumpsHuge Aug. 18 at 7:17 PM

$WINT is a new $DRUG come join the squeeze $MSFT $SPY $GOOGL

0 · Reply

EverythingIBuyPumpsHuge Aug. 18 at 7:17 PM

$WINT is new $DRUG come join the squeeze $APPL $NVDA $META

0 · Reply

EverythingIBuyPumpsHuge Aug. 18 at 7:16 PM

$WINT is new $DRUG come join the squeeze $LILY $QQQ $SPY

0 · Reply

biochirp Aug. 18 at 5:13 PM

$DRUG lets go

0 · Reply

EverythingIBuyPumpsHuge Aug. 18 at 4:09 PM

$WINT is the new $DRUG - please read HUGE recent news shorts do not want you to know $SPY $QQQ $MSFT

0 · Reply

EverythingIBuyPumpsHuge Aug. 18 at 3:17 PM

$WINT news shorts do not want you to know - this is the newxt $DRUG

0 · Reply

EverythingIBuyPumpsHuge Aug. 18 at 3:15 PM

$WINT HUGE short squeeze ahead - please read news and do your own dd $CVNA $HKD $DRUG $LLY

0 · Reply

Bright Minds Biosciences Announces Featured Speakers for its Absence Epilepsy Virtual R&D Day on May 20, 2025

May 7, 2025, 4:45 PM EDT - 3 months ago

Epilepsy-Focused Bright Minds Biosciences A High-Risk, High-Reward Play, Analyst Initiates With Over 150% Stock Upside

Apr 28, 2025, 8:00 AM EDT - 4 months ago

Bright Minds Biosciences to Host Virtual R&D Day on May 20, 2025; Program Highlights Include an Overview of Absence Seizures and the BMB-101 Phase 2 Study

Apr 16, 2025, 12:09 PM EDT - 4 months ago

Bright Minds Biosciences: A Buy With A Major Catalyst In Q2 2025

Jan 26, 2025, 6:32 AM EST - 7 months ago

Bright Minds Biosciences: Looking To Change Scope Of Epilepsy Disorder Treatments With BMB-101

Jan 7, 2025, 6:50 AM EST - 7 months ago

Bright Minds Biosciences Appoints Pharmaceutical Leader, Stephen Collins, M.D., Ph.D., as Chief Medical Officer

Nov 4, 2024, 2:41 PM EST - 10 months ago

Bright Minds Biosciences Closes US$35 Million Non-Brokered Private Placement

Oct 30, 2024, 1:07 AM EDT - 10 months ago

Bright Minds Biosciences: BMB-101's Phase 2 Trials Could Unlock Epilepsy Market Potential

Oct 28, 2024, 8:21 AM EDT - 10 months ago

PESG Releases Market Update: Nuvectis Pharma Shows Promising Synergy for NXP900 in Recent Presentations; Growing Anticipation for Upcoming NXP800 Data Update

NVCT

Oct 21, 2024, 8:30 AM EDT - 10 months ago

Bright Minds Biosciences and Firefly Neuroscience to Collaborate After the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy for Full Analysis of EEG Data

Oct 18, 2024, 6:50 AM EDT - 10 months ago

Bright Minds Biosciences Announces US$35 Million Non-Brokered Private Placement

Oct 16, 2024, 10:45 AM EDT - 10 months ago

Bright Minds Biosciences proprietary compound, BMB-201, 5-HT2C/2A mixed agonist, demonstrated similar efficacy to morphine in preclinical pain models

Oct 15, 2024, 9:09 PM EDT - 10 months ago

Bright Minds is Unaware of Any Material Changes

Oct 3, 2024, 9:00 AM EDT - 11 months ago

Bright Minds Biosciences announces participation in upcoming scientific conferences and partnering events

Sep 19, 2024, 10:00 AM EDT - 11 months ago

Bright Minds Biosciences to Host Investor & Analyst KOL Event on September 25th

Sep 12, 2024, 8:00 AM EDT - 1 year ago

Bright Minds Biosciences Initiates the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy

Aug 8, 2023, 6:50 AM EDT - 2 years ago

Bright Minds Biosciences Announces Positive qEEG (Quantitative Electroencephalogram) Data from its First-in-Human Phase 1 Study of Lead Compound, BMB-101

Jul 20, 2023, 6:50 AM EDT - 2 years ago

Bright Minds Biosciences Announces Positive Topline Data for its First-in-Human Phase 1 Study of Lead Compound, BMB-101

Jul 12, 2023, 10:33 AM EDT - 2 years ago

CSE Bulletin: Consolidation - Bright Minds Biosciences Inc. (DRUG)

Jul 11, 2023, 6:50 AM EDT - 2 years ago

Bright Minds Announces Effective Date of Share Consolidation

Jun 22, 2023, 6:50 AM EDT - 2 years ago

Bright Minds Announces Proposed Share Consolidation

Apr 19, 2023, 6:50 AM EDT - 2 years ago

Bright Minds Biosciences Receives a Favorable Written Opinion from the International Searching Authority for BMB-202

Apr 10, 2023, 6:50 AM EDT - 2 years ago

Bright Minds Biosciences to Present at the 20th International Meeting of the International Society for Serotonin Research

Feb 27, 2023, 6:50 AM EST - 2 years ago

Bright Minds Biosciences Provides Clinical Program Updates and Outlines Anticipated Milestones for 2023

Feb 17, 2023, 6:50 AM EST - 2 years ago

Bright Minds Biosciences Announces Non-Executive Director Appointment

Feb 8, 2023, 4:05 PM EST - 2 years ago

Bright Minds Biosciences Announces Receipt of Nasdaq Deficiency Letter Regarding Independent Director and Audit Committee Requirements

Jan 27, 2023, 4:05 PM EST - 2 years ago

Bright Minds Biosciences Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

Jan 9, 2023, 4:05 PM EST - 2 years ago

Bright Minds Biosciences Announces Resignation of Board Member

Dec 2, 2022, 7:07 PM EST - 2 years ago

Bright Minds Biosciences Announces Closing of Non-Brokered Private Placement

Nov 28, 2022, 6:50 AM EST - 2 years ago

Bright Minds Biosciences Announces Non-Brokered Private Placement

Nov 23, 2022, 11:35 AM EST - 2 years ago

Bright Minds Biosciences Appoints Drug Development Executive Mark A. Smith M.D.

Sep 7, 2022, 6:50 AM EDT - 3 years ago

Bright Minds Biosciences Announces Appointment of Doug Williamson to Board of Directors

Aug 31, 2022, 6:50 AM EDT - 3 years ago

Bright Minds Biosciences Initiates Dosing in Phase I Clinical Trial of BMB-101 for Dravet Syndrome

Aug 30, 2022, 3:35 PM EDT - 3 years ago

Bright Minds Biosciences Announces Closing of $4 Million Unit Offering

Aug 23, 2022, 9:07 PM EDT - 3 years ago

Bright Minds Announces Pricing of Overnight Marketed Offering of Units

Aug 22, 2022, 7:05 PM EDT - 3 years ago

Bright Minds Announces Overnight Marketed Offering of Units

Aug 18, 2022, 3:34 PM EDT - 3 years ago

Bright Minds Biosciences Comments on Recent Trading Activity

Jun 27, 2022, 6:50 AM EDT - 3 years ago

Bright Minds Biosciences Announces Changes to its Executive Leadership Team, Marking the Transition to a Development Organization

May 12, 2022, 6:50 AM EDT - 3 years ago

Bright Minds Biosciences to Host Key Opinion Leader Symposium on Dravet Syndrome

May 2, 2022, 6:50 AM EDT - 3 years ago

Bright Minds Biosciences Establishes Scientific Advisory Board, Comprising Five Preeminent Physicians and Scientists Across Mental Health Specialties

Nov 30, 2021, 7:30 AM EST - 4 years ago

Bright Minds Biosciences Provides Scientific Update on its Novel 5-HT2A Psychedelic Program for the Treatment of Mental Diseases

Nov 4, 2021, 8:52 AM EDT - 4 years ago

Bright Minds Biosciences: Newest Psychedelics Company To Join The Nasdaq

Nov 3, 2021, 6:50 AM EDT - 4 years ago

Bright Minds Biosciences Commences Trading on the Nasdaq Under the Ticker Symbol “DRUG”

EverythingIBuyPumpsHuge Aug. 18 at 7:20 PM

$WINT is a new $DRUG come join the squeeze $KIDZ $INTC $AMZN

0 · Reply

EverythingIBuyPumpsHuge Aug. 18 at 7:20 PM

$WINT is a new $DRUG come join the squeeze $ASST $ASBP $ETH.X

0 · Reply

EverythingIBuyPumpsHuge Aug. 18 at 7:18 PM

$WINT is a new $DRUG come join the squeeze $COIN $BTC.X $HKD

0 · Reply

EverythingIBuyPumpsHuge Aug. 18 at 7:17 PM

$WINT is a new $DRUG come join the squeeze $MSFT $SPY $GOOGL

0 · Reply

EverythingIBuyPumpsHuge Aug. 18 at 7:17 PM

$WINT is new $DRUG come join the squeeze $APPL $NVDA $META

0 · Reply

EverythingIBuyPumpsHuge Aug. 18 at 7:16 PM

$WINT is new $DRUG come join the squeeze $LILY $QQQ $SPY

0 · Reply

biochirp Aug. 18 at 5:13 PM

$DRUG lets go

0 · Reply

EverythingIBuyPumpsHuge Aug. 18 at 4:09 PM

$WINT is the new $DRUG - please read HUGE recent news shorts do not want you to know $SPY $QQQ $MSFT

0 · Reply

EverythingIBuyPumpsHuge Aug. 18 at 3:17 PM

$WINT news shorts do not want you to know - this is the newxt $DRUG

0 · Reply

EverythingIBuyPumpsHuge Aug. 18 at 3:15 PM

$WINT HUGE short squeeze ahead - please read news and do your own dd $CVNA $HKD $DRUG $LLY

0 · Reply

CalculatedSwing Aug. 18 at 12:35 PM

$DRUG check $GLMD

0 · Reply

EverythingIBuyPumpsHuge Aug. 18 at 12:13 PM

$WINT watch the news, here we go, WINT is a new $DRUG -

0 · Reply

Stock_Catcher Aug. 18 at 2:02 AM

Money Monday Watchlist Pt. 10 $GEVO $MVIS $DRUG $NLSP $TGL Let's Have an Amazing Week 💵

1 · Reply

Stock_Catcher Aug. 16 at 11:34 PM

Made A New Video for Bullish Analysis as well on $VERB $DRUG $CODX $CGC $ACB https://www.youtube.com/watch?v=Uq9mPSCeQ1g

0 · Reply

stocktickerboard Aug. 16 at 5:25 PM

$DRUG Symbol: GRLF (Green Leaf Innovations, Inc.) Second quarter sales surged 66% over first quarter. https://x.com/otcgrlf/status/1956400209782579304 Such a great upside for the stock as the offering statement was withdrawn. https://www.otcmarkets.com/filing/html?id=18702806&guid=x7E-kWiuIQNvJth

0 · Reply

Doozio Aug. 16 at 10:28 AM

$ARQT FRYday closes wen yo on $DRUG zzzz during 🐒🍌🧠⏰♾️

0 · Reply

Doozio Aug. 16 at 10:25 AM

All the $DRUG s are a 🎁 during 🐒🍌🧠⏰♾️

0 · Reply

EverythingIBuyPumpsHuge Aug. 16 at 9:27 AM

$WINT same development as $DRUG - whoever sold will regret until the rest of their lives https://fintel.io/topic/what-is-the-markets-opinion-on-drug-86-4286

1 · Reply

laurenlee Aug. 15 at 8:54 PM

$BTAI $DRUG run 🫦

0 · Reply

laurenlee Aug. 15 at 8:49 PM

$BTAI Please do a $DRUG run

1 · Reply

Stonkman88 Aug. 15 at 8:48 AM

$ATCH $BSLK $DRUG $NUKK

0 · Reply

Trick2MoneyisHavingSum Aug. 15 at 5:59 AM

$ATCH in Friday's premarket let's pull a $BSLK and $DRUG let's $NUKK the shorts and have a Perfect Moment - no pun intended

0 · Reply

Market Cap	294.58M
Revenue (ttm)	0.00
Net Income (ttm)	-2.06M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	40,513
Avg Vol	50,404
Day's Range	N/A - N/A
Shares Out	7.04M
Stochastic %K	75%
Beta	-6.07
Analysts	Strong Sell
Price Target	$83.25